Wang, George Sam
Bourne, David W. A.
Klawitter, Jost
Sempio, Cristina
Chapman, Kevin
Knupp, Kelly
Wempe, Michael F.
Borgelt, Laura
Christians, Uwe
Leonard, Jan
Heard, Kennon
Bajaj, Lalit
Funding for this research was provided by:
Colorado Department of Public Health and Environment (18-103031)
Article History
First Online: 12 February 2020
Compliance with Ethical Standards
:
: This work was supported by the Colorado Department of Public Health and Environment Medical Marijuana Grant Program (18-103031, to George Sam Wang, David W.A. Bourne, Jost Klawitter, Cristina Sempio, Uwe Christians, Kevin Chapman, Kelly Knupp, Laura Borgelt, Michael F. Wempe, and Lalit Bajaj). George Sam Wang has received royalties from UpToDate, and is a co-investigator on grant NIH1R01DA045051-01A1 on related subjects. Laura Borgelt has received funding for research from the Colorado Department of Public Health and Environment and honoraria for providing continuing education from PharmCon, Inc. on related subjects. Kelly Knupp was a consultant for GW pharmaceuticals and participated in drug safety and monitoring board.
: George Sam Wang, David W. A. Bourne, Jost Klawitter, Cristina Sempio, Kevin Chapman, Kelly Knupp, Michael F. Wempe, Laura Borgelt, Uwe Christians, Jan Leonard, Kennon Heard, and Lalit Bajaj have no conflicts of interest that are directly relevant to the content of this article.